Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.850
+0.150 (3.19%)
Oct 7, 2025, 3:59 PM EDT
Veradigm Market Cap
Veradigm has a market cap or net worth of $511.83 million as of October 7, 2025. Its market cap has decreased by -68.96% in one year.
Market Cap
511.83M
Enterprise Value
284.68M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.85
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 511.83M, an increase of 64.14%. That is a compound annual growth rate of 2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 528.17M | -68.05% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |
| Jushi Holdings | 157.36M |